342 related articles for article (PubMed ID: 17634847)
21. Detection of cervical lymph node metastases of nasopharyngeal carcinomas with technetium-99m tetrofosmin single photon emission computed tomography and comparison with computed tomography.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Anticancer Res; 2001; 21(1B):723-6. PubMed ID: 11299833
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m tetrofosmin SPECT predicts chemotherapy response in small cell lung cancer.
Yeh JJ; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Tumour Biol; 2003; 24(3):151-5. PubMed ID: 14610319
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation for degree of malignancy and prognosis of patients with brain glioma using 99Tcm-MIBI brain SPECT].
Fan YX; Luo RC; Li GP; Zheng H; Huang K
Ai Zheng; 2004 Jun; 23(6):689-92. PubMed ID: 15191672
[TBL] [Abstract][Full Text] [Related]
24. The role of 99mTc-tetrofosmin scintigraphy for staging patients with laryngeal cancer.
Fattori B; Grosso M; Nacci A; Bianchi F; Cosottini M; Ursino F; Manca G; Rubello D; Strauss HW; Mariani G
Cancer Biother Radiopharm; 2005 Feb; 20(1):27-35. PubMed ID: 15778576
[TBL] [Abstract][Full Text] [Related]
25. Monitoring glioma growth and tumor necrosis with the U-SPECT-II/CT scanner by targeting integrin αvβ3.
Shao G; Zhou Y; Wang F; Liu S
Mol Imaging; 2013; 12(1):39-48. PubMed ID: 23348790
[TBL] [Abstract][Full Text] [Related]
26. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.
Krengli M; Loi G; Sacchetti G; Manfredda I; Gambaro G; Brambilla M; Carriero A; Inglese E
Strahlenther Onkol; 2007 Dec; 183(12):689-94. PubMed ID: 18040614
[TBL] [Abstract][Full Text] [Related]
27. Role of Tc-glucoheptonic acid brain single photon emission computed tomography in differentiation of recurrent brain tumour and post-radiation gliosis.
Barai S; Bandopadhayaya GP; Julka PK; Naik KK; Haloi AK; Kumar R; Seith A; Malhotra A
Australas Radiol; 2004 Sep; 48(3):296-301. PubMed ID: 15344976
[TBL] [Abstract][Full Text] [Related]
28. [
Rani N; Singh B; Kumar N; Singh P; Hazari PP; Vyas S; Hooda M; Chitkara A; Shekhawat AS; Gupta SK; Radotra BD; Mishra AK
Cancer Biother Radiopharm; 2021 Sep; 36(7):568-578. PubMed ID: 32644819
[No Abstract] [Full Text] [Related]
29. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
30. 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma.
Beauchesne P; Pedeux R; Boniol M; Soler C
J Nucl Med; 2004 Mar; 45(3):409-13. PubMed ID: 15001680
[TBL] [Abstract][Full Text] [Related]
31. Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.
Amin A; Moustafa H; Ahmed E; El-Toukhy M
J Neurooncol; 2012 Feb; 106(3):579-87. PubMed ID: 21912937
[TBL] [Abstract][Full Text] [Related]
32. Brain SPECT by 99mTc-tetrofosmin for the differentiation of tumor recurrence from radiation injury.
Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
J Nucl Med; 2008 Oct; 49(10):1733-4; author reply 1734. PubMed ID: 18794274
[No Abstract] [Full Text] [Related]
33. [99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors.
Schillaci O; Spanu A; Madeddu G
Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):133-44. PubMed ID: 16010251
[TBL] [Abstract][Full Text] [Related]
34. Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies.
Le Jeune FP; Dubois F; Blond S; Steinling M
J Neurooncol; 2006 Apr; 77(2):177-83. PubMed ID: 16314957
[TBL] [Abstract][Full Text] [Related]
35. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
36. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
38. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
[TBL] [Abstract][Full Text] [Related]
39. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
Stokkel M; Stevens H; Taphoorn M; Van Rijk P
Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
[TBL] [Abstract][Full Text] [Related]
40. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
Soricelli A; Cuocolo A; Varrone A; Discepolo A; Tedeschi E; Mainenti PP; Grivet-Fojaja MR; Covelli EM; Postiglione A; Salvatore M
J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]